4dmedical Stock Revenue
| 4DX Stock | 0.46 0.01 2.22% |
4Dmedical fundamentals help investors to digest information that contributes to 4Dmedical's financial success or failures. It also enables traders to predict the movement of 4Dmedical Stock. The fundamental analysis module provides a way to measure 4Dmedical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to 4Dmedical stock.
| Last Reported | Projected for Next Year | ||
| Total Revenue | 3.8 M | 3.9 M |
4Dmedical | Revenue |
4Dmedical Company Revenue Analysis
4Dmedical's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current 4Dmedical Revenue | 3.75 M |
Most of 4Dmedical's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, 4Dmedical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Historical and Projected quarterly revenue of 4Dmedical
Projected quarterly revenue analysis of 4Dmedical provides investors and stakeholders with an insight into the company's performance and growth prospects. When actual revenues of 4Dmedical match or exceed analyst estimates, it positively influences investor confidence and market perception, often leading to a rise in 4Dmedical's stock price.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
4Dmedical Current Deferred Revenue
Current Deferred Revenue |
|
Based on the latest financial disclosure, 4Dmedical reported 3.75 M of revenue. This is 99.95% lower than that of the Health Care Equipment & Supplies sector and 99.85% lower than that of the Health Care industry. The revenue for all Australia stocks is 99.96% higher than that of the company.
4Dmedical Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses 4Dmedical's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of 4Dmedical could also be used in its relative valuation, which is a method of valuing 4Dmedical by comparing valuation metrics of similar companies.4Dmedical is currently under evaluation in revenue category among its peers.
4Dmedical Fundamentals
| Return On Equity | -0.51 | ||||
| Return On Asset | -0.27 | ||||
| Operating Margin | (7.55) % | ||||
| Current Valuation | 163.85 M | ||||
| Shares Outstanding | 411.6 M | ||||
| Shares Owned By Insiders | 21.96 % | ||||
| Shares Owned By Institutions | 5.64 % | ||||
| Price To Book | 2.67 X | ||||
| Price To Sales | 50.43 X | ||||
| Revenue | 3.75 M | ||||
| Gross Profit | 684.43 K | ||||
| EBITDA | (31.86 M) | ||||
| Net Income | (35.98 M) | ||||
| Total Debt | 5.12 M | ||||
| Book Value Per Share | 0.17 X | ||||
| Cash Flow From Operations | (30.87 M) | ||||
| Earnings Per Share | (0.10) X | ||||
| Target Price | 0.9 | ||||
| Number Of Employees | 145 | ||||
| Beta | 1.34 | ||||
| Market Capitalization | 189.34 M | ||||
| Total Asset | 120.02 M | ||||
| Retained Earnings | (152.04 M) | ||||
| Working Capital | 17.16 M | ||||
| Net Asset | 120.02 M |
About 4Dmedical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze 4Dmedical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of 4Dmedical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of 4Dmedical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for 4Dmedical Stock Analysis
When running 4Dmedical's price analysis, check to measure 4Dmedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 4Dmedical is operating at the current time. Most of 4Dmedical's value examination focuses on studying past and present price action to predict the probability of 4Dmedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 4Dmedical's price. Additionally, you may evaluate how the addition of 4Dmedical to your portfolios can decrease your overall portfolio volatility.